197 related articles for article (PubMed ID: 9389707)
1. Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: possible correlation with sensitivity to chemotherapy.
Iijima N; Miyamura K; Itou T; Tanimoto M; Sobue R; Saito H
Blood; 1997 Dec; 90(12):4901-9. PubMed ID: 9389707
[TBL] [Abstract][Full Text] [Related]
2. Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway.
Dror Y; Freedman MH
Blood; 2001 May; 97(10):3011-6. PubMed ID: 11342425
[TBL] [Abstract][Full Text] [Related]
3. Role of CD95/Fas and its ligand in the regulation of the growth of human CD34(++)CD38(-) fetal liver cells.
Bárcena A; Muench MO; Song KS; Ohkubo T; Harrison MR
Exp Hematol; 1999 Sep; 27(9):1428-39. PubMed ID: 10480434
[TBL] [Abstract][Full Text] [Related]
4. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
[TBL] [Abstract][Full Text] [Related]
5. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
6. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.
Lewis NR; Pallis M; Russell NH
Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243
[TBL] [Abstract][Full Text] [Related]
7. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.
Feuring-Buske M; Hogge DE
Blood; 2001 Jun; 97(12):3882-9. PubMed ID: 11389030
[TBL] [Abstract][Full Text] [Related]
8. Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis.
Josefsen D; Myklebust JH; Lynch DH; Stokke T; Blomhoff HK; Smeland EB
Exp Hematol; 1999 Sep; 27(9):1451-9. PubMed ID: 10480436
[TBL] [Abstract][Full Text] [Related]
9. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia.
George AA; Franklin J; Kerkof K; Shah AJ; Price M; Tsark E; Bockstoce D; Yao D; Hart N; Carcich S; Parkman R; Crooks GM; Weinberg K
Blood; 2001 Jun; 97(12):3925-30. PubMed ID: 11389036
[TBL] [Abstract][Full Text] [Related]
10. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D
Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751
[TBL] [Abstract][Full Text] [Related]
11. CD38 ligation inhibits normal and leukemic myelopoiesis.
Todisco E; Suzuki T; Srivannaboon K; Coustan-Smith E; Raimondi SC; Behm FG; Kitanaka A; Campana D
Blood; 2000 Jan; 95(2):535-42. PubMed ID: 10627459
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit(+)CD33(-)CD38(-) fraction of umbilical cord CD34(+) cells.
Liu H; Verfaillie CM
Exp Hematol; 2002 Jun; 30(6):582-9. PubMed ID: 12063025
[TBL] [Abstract][Full Text] [Related]
13. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
Prus E; Fibach E
Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
[TBL] [Abstract][Full Text] [Related]
16. In vitro identification of single CD34+CD38- cells with both lymphoid and myeloid potential.
Hao QL; Smogorzewska EM; Barsky LW; Crooks GM
Blood; 1998 Jun; 91(11):4145-51. PubMed ID: 9596660
[TBL] [Abstract][Full Text] [Related]
17. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.
Xiao M; Oppenlander BK; Plunkett JM; Dooley DC
Exp Hematol; 1999 May; 27(5):916-27. PubMed ID: 10340408
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic regulation in primitive hematopoietic precursors.
Peters R; Leyvraz S; Perey L
Blood; 1998 Sep; 92(6):2041-52. PubMed ID: 9731062
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
[TBL] [Abstract][Full Text] [Related]
20. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia.
Turhan AG; Lemoine FM; Debert C; Bonnet ML; Baillou C; Picard F; Macintyre EA; Varet B
Blood; 1995 Apr; 85(8):2154-61. PubMed ID: 7536493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
